STERIS

News

Mentor, Ohio: City of opportunity for medical technology jobs

All of a sudden, Mentor, Ohio, has become a hot spot for job growth in medical device and equipment companies. STERIS Corp. (NYSE: STE), the maker of contamination-control technologies, as well as sophisticated operating room equipment, is closing a leased facility in Erie, Penn. and plans to transfer most of the 240 jobs to Mentor […]

Policy

STERIS settles System 1 dispute with FDA; plans customer rebates

Updated 5:58 p.m. STERIS Corp. (NYSE: STE) has settled with the Food and Drug Administration, addressing the “violating device” status of the company’s System 1 liquid chemical sterilizer and fleshing out a transition plan that will enable U.S. customers–mostly hospitals and surgical centers–to trade in their System 1s for rebates. The terms of the consent […]

presented by
Policy

FDA clears for market next generation STERIS System 1E

After more than a year of review, the Food and Drug Administration has cleared for market the next-generation liquid chemical sterilizing system–System 1E–of STERIS Corp. The Mentor, Ohio, maker of health and life sciences technologies hopes to deliver the first System 1Es by the quarter ending Sept. 30. Until then, it will continue working with […]

News

STERIS inks development deal with filtration company

Sterilization-products maker STERIS Corp. has signed a development agreement with a New Jersey firm that specializes in filtration products. STERIS and River Edge, N.J.-based Nephros Inc. “will jointly develop filtration-based products for medical device applications,” according to a statement from Nephros. The statement doesn’t get any more specific than that and Stephen Norton, a STERIS […]

News

STERIS debuts technology integration system at nurses’ congress

Mentor, Ohio’s, STERIS Corp. has introduced at the Association of periOperative Registered Nurses Congress in Denver, Colorado, a system that integrates operating room visualization technologies on a single touch screen. The Harmony iQ 2100 Integration System, a joint product with VTS Medical Systems LLC in Melville, N.Y., takes several units that control cameras, imaging devices […]

News

STERIS not concerned about Breeden Capital board vacancy

Robert Fields, a partner and managing director at Breeden Capital Management and Breeden Partners, quietly resigned from the STERIS Corp. board for personal reasons on March 5. Normally, the resignation of a director causes few questions. However, Fields and Richard Breeden, the former U.S. Securities and Exchange Commission chief who has since become an investment […]

presented by
presented by
Hospitals

Health reform draws lobbying dollars from big Ohio medical companies and hospitals

Issues surrounding government reimbursement and federal tax policy topped the agenda among Ohio health companies and hospitals’ major concerns last year, interviews and publicly filed lobbying reports revealed. The Cleveland Clinic, Elyria-based Invacare Corp. and Dublin-based Cardinal Health Inc. led the way in spending amongst Ohio health care organizations and companies, all spending in excess of $1 million in their federal lobbying efforts last year.

Hospitals

FDA alert about STERIS sterilization system could earn company a shareholder lawsuit — MedCity Evening Read, Dec. 15, 2009

An unnamed law firm is investigating possible securities law violations by STERIS Corp. related to the U.S. Food and Drug Administration's recommendations that health care facilities find alternatives to the company's System 1 medical instrument sterilizer, according to Shareholders Foundation Inc. in San Diego, Calif. The investigation could lead to a STERIS shareholder lawsuit.